Medtronic MiniMed Recalls

17 recalls found for Medtronic MiniMed. Check if any of your products are affected.

Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed 780G Insulin Pump Recalled for 453,144 Units Worldwide (2026)

Medtronic recalled 453,144 MiniMed 780G insulin pumps worldwide after reports of unintended insulin delivery when the pump height changes relative to the infusion site. The defect stems from gravity-driven pressure changes affecting hydrostatic delivery. Patients and caregivers should stop using the devices immediately and follow the recall notice, contacting Medtronic MiniMed or their clinician’s

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed 530G Insulin Pumps Recalled for Delivery Errors in 2026 (13,429 Units)

Medtronic recalled 13,429 MiniMed insulin pumps worldwide after identifying unintended insulin delivery errors. The issue occurs when the pump height relative to the infusion site changes, causing over-delivery or under-delivery of insulin. Patients should stop using the device and contact Medtronic for instructions.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed 740G Insulin Pump Recalled for 24,946 Units Worldwide (2026)

Medtronic MiniMed recalled 24,946 MiniMed 740G insulin pumps worldwide after identifying unintended insulin delivery when the pump height changes relative to the infusion site. The defect can cause over-delivery or under-delivery of insulin due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed for instructions on recall steps, refunds or a swap

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed Paradigm Revel Insulin Pumps Recalled: 26,647 Units Worldwide (2026)

Medtronic MiniMed recalled 26,647 Paradigm REAL-Time Revel insulin pumps distributed worldwide, including in the United States. A design flaw can cause insulin to be over- or under-delivered when the pump height changes relative to the infusion site. Patients and health providers should stop using the device immediately and follow the manufacturer’s recall instructions. The recall covers Paradigm,

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed 720G Insulin Pump Recall 2026 Affects 37,458 Units Worldwide

Medtronic MiniMed recalled 37,458 insulin pumps sold worldwide through healthcare providers, including the MiniMed 720G, after finding that a pump raised above or lowered relative to the infusion site can deliver insulin too much or too little. The defect stems from changes in gravitational force affecting hydrostatic and hydrodynamic pressures at the infusion site. Patients should stop using the

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed Paradigm Veo Insulin Pump Recalled for 55,724 Units (2026)

Medtronic MiniMed recalls 55,724 Paradigm REAL-Time Veo insulin pumps distributed worldwide. The pumps can deliver too much insulin when raised or too little when lowered relative to the infusion site due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed or their healthcare provider for instructions and refunds.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed Paradigm Real-Time Insulin Pump Recalled for 29,074 Units Worldwide (2026)

Medtronic MiniMed recalled 29,074 Paradigm Real-Time insulin pumps worldwide. The devices may deliver insulin improperly when the pump is elevated or lowered relative to the infusion site due to gravitational effects. Patients should stop using the pumps immediately and follow recall instructions from the manufacturer and their healthcare provider.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed Paradigm Insulin Pumps Recalled 73,656 Units Worldwide in 2026

Medtronic MiniMed recalled 73,656 Paradigm insulin pumps sold worldwide, including broad U.S. distribution, after a risk of unintended insulin delivery. The issue affects Paradigm, 600-series and BLE 700-series pumps. It can cause life-threatening highs or lows in insulin delivery. Stop using the device and follow recall instructions immediately.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed 630G Insulin Pumps Recalled in 2026 for Insulin Delivery Errors (60,880 Units)

Medtronic MiniMed recalled 60,880 insulin pumps sold worldwide through healthcare providers and medical distributors, including the MiniMed 630G line. The defect is gravity related and can cause insulin over-delivery or under-delivery when the pump height changes relative to the infusion site. Patients should stop using the pumps immediately and follow recall instructions.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed 770G Insulin Pump Recall Affects 95,704 Units Worldwide (2026)

Medtronic MiniMed recalled 95,704 MiniMed 770G insulin pumps worldwide after finding insulin delivery can misbehave when the pump height changes. Over-delivery can cause severe hypoglycemia and death; under-delivery can cause hyperglycemia and death. Stop using the device and follow the manufacturer’s recall instructions immediately.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed Recalled 116,645 Insulin Pumps Over Delivery Risk (2026)

Medtronic MiniMed recalled 116,645 MiniMed 640G insulin pumps worldwide, including the United States. The devices can deliver too much or too little insulin when the pump height changes relative to the infusion site due to gravity-driven pressure shifts. Stop using the pump immediately and contact Medtronic MiniMed or your healthcare provider for guidance.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed 620G Insulin Pump Recall Impacts 799 Units Worldwide (2026)

Medtronic MiniMed recalled 799 infusion pumps worldwide, including in the United States. The devices in the Paradigm, 600, and BLE 700 series can deliver too much or too little insulin when their height relative to the infusion site changes due to gravity. Stop using the pump immediately and contact Medtronic MiniMed for instructions on replacement or refund.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed 700G Insulin Pump Recalled for Insulin Delivery Errors (13,811 Units, 2026)

Medtronic MiniMed recalled 13,811 MiniMed 700G insulin pumps sold worldwide through multiple retailers. The pumps can deliver too much or too little insulin when the pump height relative to the infusion site changes due to gravity. Consumers should stop using the device and follow recall instructions in the letter notice sent to affected users.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed 780G Recall 2026: 26,851 Pumps Hit Over Software Defects

Medtronic MiniMed recalled 26,851 MiniMed 780G insulin pumps sold worldwide, including the United States and Israel. Three software defects tied to updates 6.60, 6.61, and 6.62 could misdose insulin. Stop using the affected pumps and follow the recall letter for instructions.

Medtronic MiniMed
Three software
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed 780G Insulin Pump Recalled Over Software Issue

Medtronic MiniMed recalled 577 units of the MiniMed 780G insulin pump on November 2, 2025. A software flaw in version 6.60 may cause insulin delivery to suspend unexpectedly, posing serious health risks. Patients should stop using the device immediately and follow recall instructions.

Medtronic MiniMed
A software
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed CareLink Clinic Recall 12,126 Units Worldwide in 2025

Medtronic MiniMed recalled 12,126 CareLink Clinic units worldwide after a software error misdisplays the 24-hour Sensor Glucose Overview Graph. The faulty software could prompt clinicians and patients to make therapy decisions based on incorrect glucose data. Patients should stop using the device immediately and contact Medtronic MiniMed or their healthcare provider for instructions.

Medtronic MiniMed
Software error
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medtronic MiniMed Recalls 1,440 Simplera Sensor Units Over Label Adhesion Risk (2025)

Medtronic MiniMed recalled 1,440 Simplera Sensor units distributed outside the United States after a device cap label may not adhere, risking sterility. The defect could increase infection risk. Patients and healthcare providers should stop using the device and follow recall instructions provided by Medtronic MiniMed or their healthcare provider.

Medtronic MiniMed
The device
Read more